| Date Filed | Type | Description |
| 12/13/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 23 shares
@ $1.39, valued at
$32 |
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 24 shares
@ $5.71, valued at
$137 |
|
| 07/02/2021 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 24 shares
@ $5.81, valued at
$139.4 |
|
| 06/14/2021 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 354 shares
@ $3.9185, valued at
$1.4k
|
|
| 04/02/2021 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 28 shares
@ $5.47, valued at
$153.2 |
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 66 shares
@ $4.8705, valued at
$321.5 |
|
| 10/02/2020 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 350 shares
@ $0.33, valued at
$115.5 |
|
| 08/24/2020 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 270,000 options to buy
@ $0.48, valued at
$129.6k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.5525, valued at
$552.5 |
|
| 04/02/2020 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 416 shares
@ $0.33, valued at
$137.3 |
|
| 02/03/2020 |
3
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 3 on HTG MOLECULAR DIAGNOSTICS, INC |